FLT3 and neoplasm: In vitro cytotoxicity studies on two cell lines (OCI-AML3 and THP1) demonstrate that FLT3-loaded GNP are promising candidates as vehicles for anti-tumor drugs and show superior therapeutic effect than the freely administered drugs.